Related references
Note: Only part of the references are listed.Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
Helen E. Heslop et al.
BLOOD (2010)
ISCOMATRIX Adjuvant Induces Efficient Cross-Presentation of Tumor Antigen by Dendritic Cells via Rapid Cytosolic Antigen Delivery and Processing via Tripeptidyl Peptidase II
Max Schnurr et al.
JOURNAL OF IMMUNOLOGY (2009)
Widespread sequence variation in Epstein-Barr virus nuclear antigen 1 influences the antiviral T cell response
Melissa J. Bell et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Preferential binding of unusually long peptides to MHC class I and its influence on the selection of target peptides for T cell recognition
Jacqueline M. Burrows et al.
MOLECULAR IMMUNOLOGY (2008)
A major EBNA1 variant from Asian EBV isolates shows enhanced transcriptional activity compared to prototype B95.8
Nguyen-Van Do et al.
VIRUS RESEARCH (2008)
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial
Tanzina Haque et al.
BLOOD (2007)
Immunity, homing and efficacy of allogeneic adoptive immunotherapy for posttransplant lymphoproliferative disorders
M. K. Gandhi et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Influence of translation efficiency of homologous viral proteins on the endogenous presentation of CD8+ T cell epitopes
Judy Tellam et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule
Fleur E. Tynan et al.
NATURE IMMUNOLOGY (2007)
Epstein-Barr virus T-cell immunity despite rituximab
Angela K. Nehring et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Functional reversion of antigen-specific CD8+ T cells from patients with Hodgkin lymphoma following in vitro stimulation with recombinant polyepitope
Corey Smith et al.
JOURNAL OF IMMUNOLOGY (2006)
Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients
Maher K. Gandhi et al.
BLOOD (2006)
Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins
D Adhikary et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-hodgkin lymphoma
E Piriou et al.
BLOOD (2005)
Treatment of nasopharyngeal carcinoma with Epstein-Barr virus-specific T lymphocytes
KCM Straathof et al.
BLOOD (2005)
Technology Insight: applications of emerging immunotherapeutic strategies for Epstein-Barr virus-associated malignancies
R Khanna et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2005)
Endogenous MHC class II processing of a viral nuclear antigen after autophagy
C Paludan et al.
SCIENCE (2005)
Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes
KS Voo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Towards a cellular definition of CD8+ T-cell memory:: the role of CD4+ T-cell help in CD8+ T-cell responses
B Rocha et al.
CURRENT OPINION IN IMMUNOLOGY (2004)
CD8 T cell recognition of endogenously expressed Epstein-Barr virus nuclear antigen 1
SP Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1
J Tellam et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Sensitive and viable identification of antigen-specific CD8+T cells by a flow cytometric assay for degranulation
MR Betts et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1
Y Yin et al.
SCIENCE (2003)
Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4+ T-helper 1 responses
A Leen et al.
JOURNAL OF VIROLOGY (2001)
An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs
S Gottschalk et al.
BLOOD (2001)
EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function
K Bickham et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
The importance of exogenous antigen in priming the human CD8+ T cell response:: Lessons from the EBV nuclear antigen EBNA1
N Blake et al.
JOURNAL OF IMMUNOLOGY (2000)
Human CD4+ T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1
C Münz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
